ETFsBloomberg MSCI EUR Corporate PAB Select Unhedged EUR
Amundi

Amundi EUR Corporate Bond Climate Paris Aligned UCITS ETF Acc

CRPX LSEAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
153.96EUR
+0.21% · +€0.33
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
CRPXBase
Fund charges
0.14%Total expense ratio (TER)
Fund size
€1.1bnall share classes
Return 1Y
-0.8%
Sharpe 3Y
0.26
Volatility 1Y
3.2%annualised
Holdings
1,845Fund holdings

Performance

Compare
  • CRPX-0.8%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
CRPX+0.7%-0.8%-0.2%-0.8%-0.8%+12.3%-0.9%
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World+0.3%-5.7%-11.0%-17.1%-16.7%-63.3%-72.1%

Risk and return

Sharpe ratio · 3Y
0.26
Below MSCI World · 1.24
Return p.a.
+3.7%
Volatility
3.5%
Max loss
-3.1%Sept 2026

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
CRPX
0.26
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
2.8%
Holdings
1,845
As of
Fund holdings
  1. 1AXA SA VAR May49 EMTNXS17996116420.41%
  2. 2CITIGROUP INC VAR May32 EMTNXS25778263860.31%
  3. 3BANQ FED CRD 4.375% Jan34 EMTNFR001400N3I50.30%
  4. 4DEUTSCHE BANK VAR Jul35 EMTNDE000A383KA90.26%
  5. 5DEUTSCHE BOER 3.875% Sep33DE000A351ZT40.25%
  6. 6CAPGEMINI SE 3.5% Sep34FR0014012S890.25%
  7. 7SAP SE 1.625% Mar31DE000A2TSTG30.25%
  8. 8NATIONWIDE BL VAR Jan36 EMTNXS29867306170.25%
  9. 9MUNICH RE VAR May49XS18434483140.24%
  10. 10ASR NEDERLAND VAR Dec43XS25545818300.23%

Countries

Classified 99.8%
Largest
23.7%United States
Top 3
50.4%
Effective number
8.41 / HHI

Market cap

Weight vs holdings

2.8%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.